A carregar...
Long-Term Follow-up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody
Because eosinophils express CD52 antigen, 12 patients with refractory or relapsed hypereosinophilic syndrome were treated with alemtuzumab, an anti-CD52 antibody. Brisk elimination of signs and symptoms of the disease was achieved in almost all patients, with durability of response better in those o...
Na minha lista:
| Publicado no: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445419/ https://ncbi.nlm.nih.gov/pubmed/23123105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.09.018 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|